Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00973856 · ClinicalTrials.gov registry record · NA
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
A NA study of Warts and Papillomavirus Infections, sponsored by Cleveland Clinic Akron General.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT00973856: Completed NA study of Warts and Papillomavirus Infections, sponsored by Cleveland Clinic Akron General.
NCT00973856 is a NA study of Warts and Papillomavirus Infections that has completed, run by Cleveland Clinic Akron General. The registered enrollment target is 5 participants, below the 221-participant average among 7 other Warts trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00973856, a NA study of Warts and Papillomavirus Infections, has completed, sponsored by Cleveland Clinic Akron General.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to conduct a pilot study to determine the effectiveness of PURELL VF481 to treat warts located on the hands.
Primary Outcome
Data is not available due to study closure and data destruction
Conditions Studied
Interventions
- OTHER PURELL VF481
- OTHER Placebo Solution
Study Locations (1)
Ohio
- Akron Dermatology - Akron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT00973856 record still lists
NCT00973856 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 221-participant average among 7 other Warts trials with a reported enrollment target (98% lower).
The record links to 4 conditions, with Warts appearing as the primary indexed condition, and to 2 interventions - of which PURELL VF481 is the first listed.
NCT00973856 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00973856 about?
NCT00973856 is a clinical study titled "Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands". The objective is to conduct a pilot study to determine the effectiveness of PURELL VF481 to treat warts located on the hands.
What is the current status of trial NCT00973856?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2009-09. Estimated completion is 2012-01.
What conditions does trial NCT00973856 study?
This clinical trial studies the following conditions: Warts, Papillomavirus Infections, Condylomata Acuminata, Epidermodysplasia Verruciformis.
What interventions are being tested in trial NCT00973856?
The interventions under investigation include: PURELL VF481 (OTHER), Placebo Solution (OTHER).
Who is sponsoring clinical trial NCT00973856?
This trial is sponsored by Cleveland Clinic Akron General, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00973856 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Warts
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Microwave Treatment of Common and Plantar Warts
ACTIVE NOT RECRUITING · NA
-
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
RECRUITING · Phase 1
-
Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
RECRUITING · Phase 2
-
Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia
RECRUITING
-
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)
RECRUITING · Phase 3
-
Candin Safety & Efficacy Study for the Treatment of Warts
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia